Eupraxia Pharmaceuticals Inc
TSX:EPRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
CA |
|
Bundamedik Tbk PT
IDX:BMHS
|
ID |
|
S
|
Supercom Ltd
F:50S
|
IL |
|
T
|
Topview Optronics Corp
TPEX:6556
|
TW |
|
PCI- PAL PLC
LSE:PCIP
|
UK |
|
P
|
PDD Holdings Inc
F:9PDA
|
CN |
|
SEB SA
OTC:SEBYF
|
FR |
|
Ferrovial SA
MAD:FER
|
ES |
|
Yangtze Optical Fibre and Cable Joint Stock Ltd Co
F:1YO
|
CN |
|
Metals X Ltd
ASX:MLX
|
AU |
|
Pluri Inc
NASDAQ:PLUR
|
IL |
|
P
|
Paladin Energy Ltd
F:PUR
|
AU |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
DE |
|
Century Lithium Corp
XTSX:LCE
|
CA |
|
Ventia Services Group Ltd
ASX:VNT
|
AU |
|
Precot Ltd
NSE:PRECOT
|
IN |
|
17 Education & Technology Group Inc
NASDAQ:YQ
|
CN |
|
U
|
UniTest Inc
KOSDAQ:086390
|
KR |
Bankruptcy Probability
Eupraxia Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eupraxia Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
753m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
77.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eupraxia Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eupraxia Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.